$ACRS Aclaris Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Aclaris Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Aclaris Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Aclaris Therapeutics, Inc. for free.

CIK Number: 0001557746
IRS Number: 460571712
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ACRS
Company Address: 640 LEE ROAD SUITE 200 WAYNE 19087
Phone number: 484-324-7933

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through Therapeutics and Contract Research segments. The Therapeutics segment focuses in identifying, developing, and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Malvern, PA.

Market Capitalization: $537.94M
Prev close: $25.25
Average Daily Volume: 309,565
Days Low: $24.86
Year Low: $14.12
Year High: $31.80

Aclaris Therapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Ali-Jackson KamilChief Legal Officer103,9782,625,445shares bought: 113,529 / shares sold: -37,117 STRONG BUYMar 04 20203 months ago
GOWEN MAXINEDirector4,438112,060shares bought: 4,438 / shares sold: 0 BUYMar 04 20203 months ago
Mehra AnandDirector8,876224,119shares bought: 380,969 / shares sold: -750,000 STRONG SELLMar 04 20203 months ago
Molineaux Christopher P.Director16,558418,090shares bought: 21,158 / shares sold: 0 STRONG BUYMar 04 20203 months ago
Powell Andrew Kenneth WilliamDirector9,376236,744shares bought: 9,376 / shares sold: 0 STRONG BUYMar 04 20203 months ago
Reasons Bryan M.Director8,876224,119shares bought: 8,876 / shares sold: 0 BUYMar 04 20203 months ago
SCHIFF DR DREWDirector8,876224,119shares bought: 117,477 / shares sold: 0 STRONG BUYMar 04 20203 months ago
Walker NealPresident and CEO1,025,05325,882,588shares bought: 308,848 / shares sold: -59,474 STRONG BUYMar 04 20203 months ago

View all Aclaris Therapeutics, Inc. insiders.

Aclaris Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 04 2020ACRSAclaris Therapeuti ...Walker NealPresident and CEOOption ExerciseM0.0052,56400
Mar 04 2020ACRSAclaris Therapeuti ...Walker NealPresident and CEOOption ExerciseA0.0052,564052,564
Mar 04 2020ACRSAclaris Therapeuti ...Walker NealPresident and CEOOption ExerciseA0.0073,015073,015
Mar 04 2020ACRSAclaris Therapeuti ...Walker NealPresident and CEOOption ExerciseA0.00146,0290146,029
Mar 04 2020ACRSAclaris Therapeuti ...Walker NealPresident and CEOOption ExerciseA1.26255,552321,996255,552
Mar 04 2020ACRSAclaris Therapeuti ...Walker NealPresident and CEOOption ExerciseM0.0096,1500288,450
Mar 04 2020ACRSAclaris Therapeuti ...Walker NealPresident and CEOPayment of ExerciseF1.2615,10119,0271,034,8931 M to 1 M (-1.44 %)
Mar 04 2020ACRSAclaris Therapeuti ...Walker NealPresident and CEOBuyM0.0052,56401,049,994997.4 K to 1 M (+5.27 %)
Mar 04 2020ACRSAclaris Therapeuti ...Walker NealPresident and CEOPayment of ExerciseF1.2627,62334,805997,4301 M to 997.4 K (-2.69 %)
Mar 04 2020ACRSAclaris Therapeuti ...Walker NealPresident and CEOBuyM0.0096,15001,025,053928.9 K to 1 M (+10.35 %)
Mar 04 2020ACRSAclaris Therapeuti ...SCHIFF ANDREW NDirectorOption ExerciseM0.008,87600
Mar 04 2020ACRSAclaris Therapeuti ...SCHIFF ANDREW NDirectorOption ExerciseA0.008,87608,876
Mar 04 2020ACRSAclaris Therapeuti ...SCHIFF ANDREW NDirectorBuyM0.008,87608,8760 to 8.9 K
Mar 04 2020ACRSAclaris Therapeuti ...Reasons Bryan M.DirectorOption ExerciseM0.008,87600
Mar 04 2020ACRSAclaris Therapeuti ...Reasons Bryan M.DirectorOption ExerciseA0.008,87608,876

View all Aclaris Therapeutics, Inc. insider transactions.